Recent analyses of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial looked at the effects of fenofibrate on gout and cardiovascular events in patients with type 2 diabetes.
Having gestational diabetes, or even elevated glucose levels during pregnancy, may be associated with increased risk of metabolic syndrome and cardiovascular disease (CVD) later, according to three recent studies.
Recent studies looked at light therapy for depression and diabetes, seasonal variation in glycemic control, and associations between outdoor sunlight and temperature and metabolism.
A study compared patients' HbA1c levels on human and analogue insulins, a report analyzed insulin price changes between 2012 and 2016, and politicians asked pharma companies for answers.
One recent study found that many patients with diabetes frequently forget to take their medications, while another analyzed the association between diabetes and brain volume and cognitive performance among older people.
Recent studies analyzed depression in diabetes, including associated causes of death, the potential benefits of peer support and a plant-based diet, and strategies for screening and treatment.
One recent study reported on the development and validation of an artificial intelligence algorithm for detecting diabetic retinopathy, while another tested such technology in primary care.
Metformin—including its use, effects, and mechanisms—was the focus of some research published in the past month.
Outcomes and costs of different classes of diabetes drugs were compared by studies published in the past month.